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Abstract
Motifs of peptides naturally associated with H-2Ek and Ed molecules were determined by (I) pool
sequencing of natural ligand mixtures and (II) sequencing of Individual natural ligands followed by
their alignment to the basic motif suggested by pool sequencing. The data reveal nine amlno acid
motifs with Interaction sites at relative positions P1, P4, P6 and P9, with specificities that are
identical at some but different at other anchor positions between Ed and Ek motifs, Illustrating the
different requirements for peptides to be presented by these two MHC molecules. The anchors with
the most restricted specificity are P1 and P9. P1 is aliphatic for Ek and predominantly aromatic for
Ed. P9 Is positively charged for both molecules. P4 and P6 show a totally different amino acid
preference between Ek and Ed ligand motifs. An alignment of Ed and Ek protein sequences to the
recently reported HLA-DR1 pocket residues Is in agreement with observed anchor residues in Ek
and Ed motifs, thus confirming the predicted similarity of mouse class II E molecules with human
DR molecules. Furthermore, this alignment was extended to the putative pockets of class II Eb and
Es molecules, and allowed, together with sequence Information of previously identified natural
ligands of Eb and E9 molecules, a prediction of their respective motifs. The Information obtained by
this study should be useful to identify putative class II E epltopes in proteins and to design
peptides for blocking class II E molecules.
Introduction
The analysis of peptides eluted from MHC class I molecules
revealed clear ligand motifs, typically characterized by a
certain peptide length and two anchor positions that have to
be occupied by closely related amino acids (1). However,
such motifs are less apparent with ligands eluted from class
II MHC molecules because these peptides vary extensively
in their length, complicating the alignment of isolated natural
ligands (2-6). Therefore, most of the information of class II
binding specificity is derived from peptide binding studies
using mutations of known T cells epitopes (7-11) or by in vitro
selection of peptides derived from phage libraries (12). These
studies have the disadvantage of being biased for peptide
binding only and do not account for influences of antigen
processing. A good example for possible discrepancies
between ligand and binding motifs is the H-2Kb motif. Whereas
all isolated Kb ligands carry a hydrophobic residue at P9, no
preference for certain amino acids at this position is detectable
in peptide binding studies (13). Furthermore, in experiments
using mutated synthetic peptides, time and money allow the
study of only a limited number of variant peptides. Therefore,
complementary effects between different anchor positions
might stay undetected, since not all combinatorial possibilities
can be studied. Recent experiments using pool sequencing
of natural ligands in combination with sequencing and align-
ment of individual peptides showed that this approach can
be used to identify motifs of class ll-associated peptides (14-
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17). The validity of these motifs is supported by the recently
published three-dimensional structure of DR1 molecules
(18,19). The structure revealed five pockets, each of which
has a certain specificity for peptide ligand side chains which
is in agreement with the peptide binding motif for DR1
molecules derived by either peptide binding studies (12) or
pool sequencing analysis (14). In order to gain more insight
into H-2E motifs and especially to understand the different
requirements for peptide binding by H-2Ek and H-2Ed molec-
ules, we analyzed natural peptide ligands of these two
molecules, using pool and individual peptide sequencing.
Even though H-2Ek and H-2Ed molecules have a high
sequence homology, the obtained ligand motifs show remark-
able differences explaining why most peptides which bind to
H-2Ek molecules do not bind to H-2Ed molecules and vice
versa. The differences in the obtained motifs are also reflected
in the putative pocket structures based on the HLA-DR
molecule. This implies, in addition to the high sequence
homology, also a high structural homology between H-2E and
HLA-DR molecules. The resulting Ek and Ed-specific motifs
were used as a basis to attempt predictions on H-2ES and
Eb motifs.
Methods
Cell lines and cell culture
As a source for Ek molecules, CH27 cells .or wt-Ek cells (20)
were used. Ed molecules were purified from A20 cells (21) or
LQ-9E10 cells (provided by Dr D. Vldovig). For bulk culture,
cells were grown in 2 I glass roller bottles (Schott Duran,
Frankfurt, Germany) at 37°C with up to 1.5-1 RPMI 1640
medium supplemented with 3.5% FCS, 3.5% newborn calf
serum, glutamine, penicillin/streptomycin and 2-mercapto-
ethanol. Cells were split every 3-4 days. For harvest, (typically
24-28 I) cell suspensions were pelleted with a continuous
flow rotor (Beckman, Munich, Germany). Cell pellets were
either used directly for peptide extraction or stored at -70°C.
Antibodies
Immunoprecipitations were performed with 14-4-4S antibod-
ies (22) specific for H-2Ek'd''s. Hybridomas were grown in
roller culture. Supernatant was filtered and the pH adjusted
to 7.5. The antibodies were further purified on a Protein A-
Sepharose column (Pharmacia, Freiburg, Germany) accord-
ing to standard protocols.
MHC precipitation and peptide extraction
This was done as described (18). Briefly, pellets (20-40 ml)
were lysed in 1% (v/v) NP-40, 1 mM phenylmethylsulphonyl
fluoride, 0.02% (w/v) pepstatin, 0.02% (w/v) leupeptin and
0.02% (w/v) aprotinin (Boehringer, Mannheim, Germany). The
lysate was ultracentrifuged for 60 min at 86,000 g. The
supernatant was passed over Sepharose beads (Pharmacia)
coupled with glycine and then over Sepharose beads coupled
with 14-4-4S antibodies. Peptides were acid-released from
the loaded beads by treatment with 0.1% (v/v) trifluoroacetic
acid (TFA). In order to remove antibody molecules and Ea-
and p-chains from the peptides, the solution was passed
through ultrafiltration membranes (Centricon 10; Amicon,
Witten, Germany) of 10,000 Da exclusion size. The filtrate
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Fig. 1. HPLC separation of H-2E ligands. Peptides eluted from
immunoprecipitated H-2Ek (A) and H-2Ed (B) molecules were
separated by reversed-phase HPLC. The numbers indicate peaks
that were sequenced individually. The sequences are listed in Tables
2 and 4. Ten percent of the volume of the numbered peaks was also
used for pool sequencing. Peaks appearing in the glycine control
(not shown) were omitted from the pools.
was separated on a reversed-phase HPLC column (u.RPC
C2/C18; 2.1x100 mm; Pharmacia), using a SMART system
(Pharmacia). Eluent A was 0.1% (v/v) TFA in water, eluent B
was 0.08% (v/v) TFA in 80% acetonitrile/water. All eluents
used were of HPLC grade (Riedel de Haen, Frankfurt,
Germany). The gradient used was the same as previously
described (14). Peptide fractions were pooled, whereby dom-
inant single peaks were used only to 10%. Pools and dominant
single peaks were sequenced separately.
Peptide analysis
Pools and single peaks were sequenced by Edman degrada-
tion on a pulsed-liquid protein sequencer 476A (Applied
Biosystems, Weiterstadt, Germany) as described (23). Cys
was not modified and therefore not detectable.
Interpretation of pool sequencing
In the raw data tables, amino acids are ordered according to
their hydropathy (24). Ordering the amino acids in this way
facilitates perception of certain physico-chemical groups clus-
tering in cycles of Edman degradation. We use two arbitrary
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Table 1. Pool sequencing of H-2Ek extracted peptides
Cycle
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Amino
I
lie
25.4
13.6
18.6
31.1
101.7
55.5
91.5
63.3
49.2
28.1
24.7
20.7
14.2
10.3
7.8
15.3
i acid i
V
val
42.2
34.2
43.7
29.4
74.9
40.6
51.2
41.3
34.3
26.5
19.8
15.8
11.0
19.0
12.7
7.7
esidues (in pmol)
L
Leu
41.8
26.8
23.2
59.4
67.4
37.2
29.3
27.0
26.4
40.0
54.0
36.7
28.7
23.8
15.5
10.2
F
Phe
14.2
11.6
7.2
7.3
8.4
28.1
38.9
35.8
18.4
14.5
9.5
11.9
8.7
6.8
4.9
4.8
W
Trp
4.1
4.4
4.5
4.8
4.8
4.5
3.6
2.9
2.3
1.9
1.7
1.5
1.3
1.1
1.0
0.9
M
Met
3R
16.0
7.6
17.4
6.6
6.7
10.0
8.1
32.7
24.0
19.6
15.3
13.8
12.1
11.8
7.6
A
Ala
28 3
41.8
22.8
26.3
14.9
19.4
21.6
29.7
22.4
30.8
20.9
20.9
12.9
10.0
7.2
5.0
Amino acids are ordered according to their hydropathy
of the same PTH-amino acid at the iprevious
G
Gly
33 1
22.3
30.9
23.5
10.9
13.3
15.5
12.5
12.7
14.5
14.5
20.4
27.6
22.6
18.3
13.2
T
Thr
?5R
10.3
24.9
15.6
10.5
13.8
4.9
4.7
5.1
5.0
3.3
2.3
1.3
2.6
2.1
2.9
S
Ser
8.3
7.5
7.3
5.3
4.8
8.6
10.2
16.3
9.9
10.6
7.2
4.8
3.6
3.6
2.7
2.5
(24). Bold numbers
position. Underlined
Y
Tyr
10.6
6.5
6.1
12.1
7.0
8.7
5.6
5.2
3.8
3.6
4.3
3.8
2.9
1.9
2.8
4.6
P
Pro
4 2
140.9
88.6
40.6
26.0
13.0
9.5
9.7
14.3
14.6
13.0
14.9
11.6
9.3
8.3
8.1
H
His
21 9
7.5
8.3
16.8
16.4
16.1
14.6
11.3
8.0
11.5
11.9
7.8
6.0
4.8
3.2
3.9
indicate increases of
numbers indicate smaller i
Q
Gin
123
14.4
19.6
22.3
13.1
18.8
11.8
29.4
31.5
38.7
19.3
15.9
8.5
6.4
6.2
5.8
>50%
ncreases or (
N
Asn
76
15.3
13.8
14.4
8.0
14.3
8.4
10.1
11.6
19.3
14.8
27.6
20.1
13.4
9.4
6.1
E
Glu
?1 2
22.1
23.7
31.1
16.9
50.5
29.8
23.8
18.0
14.2
12.9
13.1
6.9
7.0
5.5
4.3
D
Asp
14.1
15.8
20.8
25.1
23.3
24.7
18.3
17.3
12.5
9.9
7.9
7.6
6.3
7.3
8.4
7.1
K
Lys
17.2
19.4
17.2
14.2
16.0
20.5
16.8
18.3
24.4
14.0
30.1
36.3
57.8
41.2
41.1
28.4
as compared with the pmol
decreases lower than
R
Arg
2.9
2.3
7.4
7.5
6.6
8.9
9.3
9.5
22.6
18.5
18.5
28.8
32.8
35.9
27.9
20.0
amounts
expected from
tailing effects.
levels of significance for evaluation of data. An increase of
the amount of a given PTH amino acid at a given cycle of
>50% as compared with the previous cycle is considered
highly significant as indicated in bold. An increase <50% is
considered to reflect a significant signal and is indicated by
underlining the respective numbers. In some instances, a
decrease smaller than the lag effect usually found for a given
amino acid is taken as indication that some of the peptides
in the pool have this amino acid. Such values are also
underlined.
Results
Analysis of H-2E* eluted peptides
CH27 cells, expressing Ek molecules, were grown to high
cell numbers, lysed with detergent and Ek molecules were
precipitated with solid-phase bound mAb 14-4-4S. Bound
MHC molecules were treated with TFA to elute associated
peptides and the peptide containing supernatants were separ-
ated by reversed-phase HPLC (Fig. 1A). Peptides eluting in
large distinct peaks were sequenced individually by Edman
degradation. The remaining fractions were pooled and
sequenced as such. As observed with pool sequencing of
other class II ligands (14,15), a strong Pro signal was found
at cycle 2, followed by clusters of hydrophobic, polar and
charged residues (Table 1) that reflect the anchor positions
used by the ligands to bind to the class II molecule (14,15).
The appearance of anchor residues in clusters stretching
over three cycles rather than as a sharp peak confined to
one cycle is probably caused by variation in the number of
amino acids between the N-terminus and the first anchor
position. One evident cluster appearing after the Pro in cycle
2 is observed in cycles 4 and 5 consisting of aliphatic amino
acids like Val, Leu and lie. These are considered to represent
the first anchor position. The Tyr signal in cycle 4 is sharp
and therefore unlikely to be part of an anchor residue. After
this, a cluster of hydrophobic amino acids, including Phe, but
also small and polar amino acids like Ser, appears in cycles
7 and 8, considered to represent the second anchor position.
The strong and unclustered Glu signal in cycle 6 is part of
the sequence of peptide 3 in Table 2 and is therefore not
considered as part of an anchor. In cycles 9 and 10, a
significant increase of the polar residue Gin becomes evident,
with still some Asn and Ala contribution, forming the putative
third anchor position. Cycles 11-14 reflect the putative fourth
anchor position, which is dominated by strong Lys and
Arg signals, with some contribution of Gly. This information,
together with the alignment of peptides derived from single
peak sequences, leads to the basis for the detailed Ek motif
in Table 2, with four anchors at relative positions 1, 4, 6 and
9. Position 1 and 9 seem to be the most stringent ones,
allowing mainly aliphatic residues at position 1 and positive
charged residues at position 9. The anchors at positions 4
and 6 and the correlation of all anchor residues to the
predicted Ek pockets according to the DR1 crystal structure
will be discussed later.
Analysis of E? eluted peptides
Ed associated peptides were eluted from large batches of
A20or LQ-9E10 cells using the same antibody and procedure
as described for Ek bound peptides (Fig. 1B). Again, a very
strong Pro signal can be seen in cycle 2 (Table 3). After this,
hydrophobic residues, including the large, aromatic amino
acids, form the cluster interpreted to reflect the first anchor
position in cycles 4-6. From cycles 6 to 14 strong signals for
Lys and Arg dominate with the most significant values in
cycles 11-13. The very strong Gin signals in cycles 7 and 8
are most likely caused by dominant single peptides, which
also contributed to the strong Lys signals in cycles 8 and 9.
In addition to the residues thought to reflect the main anchors,
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Table 2. H-2Ek motif and ligands
Anchor residues
Natural ligands
Pam 42-56
HSC70 234-248
M.ser.alb. 347-361
C'inhib. 41-55
ER60 448-461
Unknown
a1-Antitryp. 397^10
Unknown
(Human) dead box protein
Bovine fetuin 342-
T cell epitopesc
MCC 91-103
PCC 91-104
Xrep 12-26
SWMb 66-78
EqMb 69-77
MoMb 69-77
MoHb 68-76
HEL 1-18
HEL 81-96
HEL 108-119
SNase 51-70
SNase 81-100
SNase 121-140
LLO 218-226
S A
R T D
Relative position
1 2
I
L
V
F
Y
W
3 4 5
I
L
y
E
S
e 7
2
H
A
S
8 9
K
R
H P P H I E I Q M L K J i G K K
D N R M V H F X A E F K R K
T P T L V E A A R U L G R V G
V N K E
G F P T
Q N A V O . G V K H I
Y F £ P A . N K K L
Y D R N T K S P L F V G
F A E £ G T L K
N K A E
V
A A V H Y
L H L G Y L P N Q L F R
I P G G P V R L C P f i R I R
D R S G
E
K
L
K
R
R
D
V
L
Y
H
A
A
A
V
F
S
V
G
E
D
D
R
T
G
S
E
R
Q
L
L
R
V
R
D
K
G
H
I
I
L
L
L
L
I
C
I
w
Y
L
L
I
A
A
K
T
T
T
T
E
T
V
G
A
R
A
Y
Y
A
A
A
A
A
L
A
A
P
Y
K
K
L
L
I
L
L
L
£
A
£
W
E
X
£
K
K
Y
G
G
G
N
A
V
R
A
Y
E
G
2
2
E
A
G
G
E
A
U
N
S
A
A
T
A
A
K
I
I
I
G
M
C
R
A
D
Q
A
T
T
K
L
L
L
L
K
A
C
F
G
A
F
K
A
K
K
K
K
K
R
K
K
T
K
K
K
K
K
H
G
K
M
K
G
T
K
V
E
L
D
M
N
K
V E N A K
L N I W
Peak no.
"Sequences adapted from ref. 5.
Sequences obtained from extraction not shown in Fig. 1 (A).
°T cell epitopes are from refs 10 and 25.
Table 3. Pool sequencing of H-2Ed extracted peptides
Cycle
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Amino
I
lie
41.7
27.1
17.8
23.0
33.3
34.5
54.3
41.6
23.0
47.3
38.2
47.5
31.3
17.3
13,9
10.5
acid
V
Val
44.4
38.3
27.1
19.4
45.1
27.2
30.9
34.5
45.6
34.8
27.2
27,5
24,6
13.8
9.3
8.0
residues
L
Leu
109.2
45.5
141.4
83.4
96.3
45.6
36.9
28.0
87.8
47.7
39,2
30.6
56.9
29.3
15.8
8.9
(in pmol)
F
Phe
12.5
11.8
27.0
35.0
49.4
27.9
18.6
17.1
32.0
13.0
11.6
10.2
8.4
6.1
4.4
4.0
W
Trp
3.4
2.8
3.2
4.8
33.2
18.5
19.5
13.4
7.4
4.4
2.9
2.3
2.2
1.9
1.6
1.3
M
Met
5.5
5.3
10.0
11.5
5.5
5.5
4.4
6.6
7.6
4.7
3.8
3.0
3.5
2.4
1.7
1.6
A
Ala
50.4
126.3
50.6
114.6
39.0
24.4
20.5
20.5
21.6
14.4
12.4
17.5
15.3
13.7
11.2
8.5
G
Gly
44.6
31.8
55.7
31.3
22.7
13.9
28.4
16.1
14.8
17.1
46.6
31.5
21.8
17.9
15.4
11.8
T
Thr
21.9
16.9
13.1
11.3
12.5
11.4
8.0
7.9
8.5
10.0
8.7
6.8
10.2
8.4
6.9
5.8
S
Ser
31.8
17.9
14.4
9.9
7.0
9.9
21.3
11.1
19.4
12.6
9.3
7.1
4.3
4.7
5.1
4.6
Y
Tyr
15.8
12.4
28.8
55.1
51.5
61.5
22.4
22.1
14.9
15.1
10.7
10.5
12.4
4.1
5.8
5.2
P
Pro
5.7
57.1
31.7
25.1
22.3
23.0
21.7
18.2
14.8
13.1
17.7
20.7
18.2
12.7
11.2
9.4
H
His
5.1
4.6
5,7
9.1
11.6
14.6
15.0
12.4
30.6
50.4
35.7
43.2
18.0
16.2
15.1
13.9
Q
Gin
11.4
58.1
31.5
19.2
15.3
21.8
64.8
55.2
27.0
17.4
18.7
20.6
11.4
8.3
7.5
6.2
N
Asn
3.1
6.2
5.8
5.5
4.5
8.6
8.4
8.6
6.9
6.8
6.9
6.3
8.7
7.2
7.0
5.8
E
Glu
46.2
64.7
103.7
87.1
41.9
34.7
35.6
27.6
17.2
29.4
16.1
29.4
20.6
18.3
18.0
16.5
D
Asp
23.6
35.4
29.3
27.8
21.4
19.4
19.6
16.5
14.5
11.5
11.0
9.9
7.8
8.2
7.9
8.5
K
Lys
13.2
16.9
16.0
15.2
12.4
40.9
29.7
108.7
81.4
38.9
54.7
52.7
67.7
58.6
38.5
32.8
R
Arg
15.9
8.9
7.7
20.0
15.7
48.2
38.7
47.3
47.6
60.0
75.0
111
79.9
42.7
43.5
41.2
Organization of data as in Table 1.
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Table 4. H-2Ed motif and ligands
Anchor residues
Natural ligands
IL-2R. y chain 168-182
170-182
Apo-E prec. 222-236
223-236
Unknown
Similar apolipoprotein B
Human 2211-2224
C. elegans cDNA homolog 74-87
Actin B 8-
T cell epitopes8
Ig lambda 91-108
SWM 102-118
SWM 132-146
HEL 108-119
SNase 112-129
FLU PR/8 HA 109-119
Xrep 12-26
HIV-1 gagp17 17-28
K Y L
Relative position
1 2 3 4 5 6 . 7 8 9
w
Y
F
I
L
V
K
a
i
i
L
V
£
K
R
S Q L E L R K K S R H ^ K E R
L E L R W K S R H ^ K E R
E R A E A W R Q K L H G R L
R A E A W R Q K L H G R L
A Q F M W I . . I R K R I Q . L P
S L D E H Y H I R V H L V K
G Q F Y F L I R K R I H L R
L V V D N G S G M C K A G F
E
L
F
N
E
I
K
D
S
A
A
E
L
S
R
E
A
E
W
A
S
R
K
I
L
V
Y
F
L
I
I
F
A
V
E
K
R
H
R
W
Y
R
A
L
V
K
R
K
F
I
R
L
D
N
P
E
Y
P
H
I
R
N
I
E
G
S
A
C
N
F
K
G
R
A
K
T
P
K
K
K
G
B
K
K
K
Peak no.
2,5,7
1,4
3
1
8
6
9
#
A L W F R N H F V F G G G T K V T V
T D
E Q H L R K S E
T cell epitopes adapted from ref. 24.
a cluster of aliphatic and small amino acids can be observed in
cycles 7-12. After combining this pool sequencing information
with the result of sequencing individual peptides and the
alignment of T cell epitopes, a ligand motif for Ed molecules
becomes evident which has the requirement for basic residues
at relative position 9 in common with the Ek motif (Table 4).
The other anchor residues, however, seem to differ between
Ek and Ed motifs. Whereas aromatic residues are not dominant
at the first anchor position of Ek ligands, the former are
favored in Ed-associated peptides. Also interesting is the high
frequency of positively charged residues found at position 4
(cycles 6-9), which is not observed in peptides eluted from
Ek molecules. On the other hand, polar residues like Gin and
Asn, which form the anchor at position 6 (cycles 9-12) for Ek
ligands, are not significantly represented at this position in
Ed bound peptides. Instead, aliphatic residues can be found
here. More details of the motif and differences between Ek
and Ed will be discussed below, especially in light of the
pocket compositions predicted for Ek and Ed molecules.
Discussion
In this study, we have analyzed natural peptide ligands eluted
from mouse class II E molecules in order to identify allele-
specific motifs. Pool sequencing analysis of peptides eluted
from Ek and Ed molecules revealed clusters of amino acids
that aligned well with sequences of individual peptides, and
allowed us to identify anchors at relative positions 1,4,6 and
9. In the case of the E* motif, our results fit well to the motif
derived by binding studies with 220 substitutions of the Ek-
restricted T cell epitope moth cytochrome c (MCC) 93-103
(10,11), where positions 1, 6 and 9 were identified to be
critical for binding. However, the anchor position at P4 could
not be identified in those studies, probably because of a
weaker contribution to the overall affinity of the peptide and
the fact that in peptide binding studies with mutated peptides
only one position can be studied at one time. Optimal amino
acid selections at several anchor positions can therefore
mask the influence of suboptimal amino acid selections at a
single anchor position. This might also explain why many
replacements were tolerated at the P1, P6 and P9 anchor
positions in the peptide binding assay, whereas our sequence
analysis showed a more stringent selection of amino acids
among natural ligands, especially at relative positions 1 and
9. At position 1, we find the aliphatic amino acids Vgl, Leu
and lie to be clearly favored over the aromatic residues. At
position 9, the basic residues Lys and Arg dominate with a
small contribution of Gly. Relative position 6 is mainly occupied
by large, polar residues like Asn or Gin, but smaller polar
groups like Ser and Thr, in addition to small hydrophobic
residues and Ala, are also found. For this anchor position,
peptide binding studies and pool sequencing are in perfect
agreement. We find an additional anchor at relative position
4 which is mainly formed by aliphatic and small polar amino
acids, but also Phe. The identification of P4 as an anchor
position is in agreement with the results obtained by Reay
et al. (10). When testing MCC peptide substitutions for the
influence on TCR interactions they found that only substitutions
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with V, L, I and F, which we observe at P4, preserved optimal
T cell stimulatory capacity. All 24 Ek restricted natural ligands
and T cell epitopes in Table 2 follow this ligand motif with at
least three optimal amino acids at the anchor positions P1,
P4, P6 and P9, with P1 and P9 being the most stringent
positions.
The analysis of Ed eluted peptides revealed anchors at
identical positions, but interestingly with different amino acid
preferences at positions 1, 4 and 6. At relative position 1,
bulky aromatic residues are more prominent than the smaller
hydrophobic amino acids, indicating that the corresponding
pocket in the Ed molecule might be more spacious. The
anchor at relative position 4 shows, besides weak signals for
Val and He, a very strong preference for Arg and Lys that is
not observed with peptides eluted from Ek molecules. A
contribution of positively charged amino acids to the P4
anchor of Ed ligands has been observed previously (30).
Sequencing cycles 9-11, which correspond to the third pocket
at relative position 6, show an increase of signals for aliphatic
residues and Gly, but no significant contribution of polar
amino acids like Gin and Asn. This finding might indicate that
polar interactions with the Ed molecule at this position are not
favored, as opposed to interactions of peptides with Ek
molecules. The anchor at position 9 seems to be identical to
the E* motif and is therefore again dominated by Lys and Arg
residues. Fourteen out of the 15 Ed-restricted natural ligands
and T cell epitopes follow this proposed ligand motif with the
optimal amino acid selection at at least three of the four
anchor positions with, analogous to the Ek motif, the most
stringent anchors at P1 and P9.
Since mouse class II E molecules are predicted to have a
high structural homology to human DR molecules and the
three-dimensional structure of the DR1 is known, we tried to
correlate Ek and Ed motifs obtained from pool and individual
peptide sequencing with the composition of the putative
pockets in class II E molecules. The residues predicted to
form the first pocket in E molecules differ from each other
and from DR1 only at position P86. DR1 molecules have a
Gly at this position (27), Ek molecules a Phe and Ed molecules
a Ser (28). DR1 binding peptides show a preference for
aromatic residues at the first anchor position, which is also
the case for Ed binding peptides, where P86 is also occupied
by a small amino acid. Peptides from Ek molecules, on the
other hand, have a strong preference for aliphatic residues,
which can be well explained by the dramatic reduction of the
pocket volume by the bigger side chain p86Phe. A similar
influence has been observed for peptides presented by DR5,
DR4Dw10 and DR4Dw14 where position p86 is occupied by
Val (14,17).
The second pocket, which accommodates P4 in peptides
binding to DR1 molecules, has a more degenerate specificity
than the first pocket, allowing aliphatic and also polar residues,
but does not favor positively charged amino acids. The
residues that are polymorphic between DR1 and Ek and
predicted to be part of the second pocket are f378 (Tyr ->
Val), p13 (Phe -> Ser), P74 (Ala -> Glu) and P71 (Arg -> Lys)
(26,27). These changes are in agreement with the appearance
of aliphatic and polar residues at P4 of Ek ligands. The change
of Ala to Glu at p74 can also explain why a basic residue at
P4 in some Ek-restricted T cell epitopes can be tolerated.
Basic residues are not favored in DR1 binding peptides (19),
presumably because of unfavorable electrostatic interactions
with P71 Arg, which P74 Glu in Ek molecules might compensate
for. The second pocket in Ed molecules has polymorphic
changes at positions P13 (Phe -> Ser), P74 (Ala -» Ser), P70
(Gin -> Glu) and P71 (Arg -> Ala) (26,27), giving a more
negative character to this pocket. This might explain why, in
addition to some aliphatic residues, positively charged amino
acids are favored at P4 of Ed bound peptides, whereas
negatively charged residues are not observed. Similar effects
have been observed with the composition of P4 residues in
peptides released from DR4Dw4 and DR4Dw10 molecules
(17), where p71 is changed from Lys to Glu. The increase of
the Glu signals in cycles 10 and 12 in Table 3 is not considered
significant for an anchor, since it can be read as part of the
sequence of the IL-2R y chain peptide (Table 4).
The third pocket identified in DR1 molecules makes contact
to the amino acid at relative position 6 of the peptide and
prefers small residues. The polymorphic residues predicted
to be responsible for the specificity of this pocket in Ek
molecules are (313 (Phe -> Ser) and P11 (Leu -> Cys),
which should give a polar character to this pocket. That this
prediction is correct can be seen from the strong increase of
the signals for polar residues, like Gin and Asn in cycles
8-11, building the cluster for P6 in Ek bound peptides (Table
1). A small increase for Ser and Thr is observed as well. That
the bigger polar residues are favored over the small ones
can be explained by the expected increase in the pocket
volume caused by the Leu -> Cys change. In the correspond-
ing pocket in Ed molecules, P11 Cys is changed to Val which
should make this pocket less polar and more hydrophobic.
Indeed, the pool sequencing signals for polar residues in Ed
bound peptides show no significant increase, whereas strong
signals for Val, Leu and He can be observed in cycles 8-11
(Table 3), suggesting that P6 in Ed ligands are preferentially
occupied by aliphatic residues.
The fourth pocket described for DR1 is very degenerate
and no specificity could be detected at relative position 7 for
DR1 binding peptides and natural ligands (12,14,19). Sim-
ilarly, the alignment of single peptides and pool sequence
information revealed no specific interactions at P7 for Ek
bound peptides. Of interest might be that the alignment of Ed
bound peptides shows a high frequency of positively charged
amino acids at P7 which probably contributed to the very
broad signals for Lys and Arg (cycles 6-14) in the pool
sequencing analysis. Whether or not these signals reflect an
anchor residue at P7 can not be confirmed by the putative
nature of the predicted corresponding pocket, because
H-2E molecules differ from DR molecules at p65 where Lys
is replaced by Pro, which is expected to alter the pocket
structure dramatically. The pocket number 5 for P9 of DR1
ligands is reported to have a preference for aliphatic residues,
allowing aromatic and polar residues as well (12,14). Both EK
and Ed molecules differ in their predicted pocket only in one
positron, P9. DR1 molecules have Trp and all H-2E p-chains
have a Glu (28). This difference is reflected in a strong
clustering of positively charged residues in cycles 12-14 in
the pool sequencing analysis of Ek and Ed eluted peptides
(Tables 1 and 3). Weak signals for aliphatic residues are
found as well, whereas P9 is clearly dominated by Arg and
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Table 5. Relations between HLA-DR and predicted H-2E pocket composition and preference for ligand residues
Class II molecule Pocket for relative position
P1 P4 P6 P9
DRBV0101
residues
ligand specificity
H-2Ek
P chain polymorphic residues
Ligand specificity
H-2Ed
P chain polymorphic residues
ligand specificity
H-2Eb
P chain polymorphic residues
predicted ligand specificity
H-2E3
P chain polymorphic residues
predicted ligand specificity
86Gly, 85val 13 Phe, 70 Gin, 71 Arg, 74 Ala, 78 Tyr 11 Leu, 13 Phe
Y, V, L, F, I, A, M, W L, A, I, V, M, N, Q; no positive charge A, G, S, T, P
86 Phe, 85 lie
I, L, V, F, Y, W
86 Ser, 85 lie
W, Y, F, I, L, V
86 Ser, 85 lie
W, Y, F, I, L, V
86 Leu, 85 lie
I, L, V, F, Y, W
13 Ser, 70 Gin, 71 Lys, 74 Glu, 78 Val 11 Cys, 13 Ser
9Trp
L, A, I, V, F, Y
9 Glu
I, L, F, S, A; R, K, D, E allowed Q, N, S, T, A, H, R, E K, R, G
13 Ser, 70 Glu, 71 Ala, 74 Ser, 78 Tyr 11 Val, 13 Ser 9 Glu
R, K, I, V; no negative charge I, L, V, G K, R
13 Ser, 70 Gin, 71 Lys, 74 Glu, 78 val 11 Cys, 13 Ser 9 Glu
I, L, F, S, A; R, K, D, E allowed Q, N, S, T, A, H, R, E K, R
13 Ser, 70 Gin, 71 Arg, 74 Ala, 78 Val 11 Ser, 13 Ser 9 Glu
L, I, V, T, S, N, Q; no positive charge Q, N, S, T, A, H, R, E K, R
Lys. A similar preference of basic amino acids at the P9
anchor of isolated ligands is observed for the HLA-DRB5*0101
molecule, where the corresponding pocket has a negative
character (29). Also interesting is the finding that some Ed
ligands seem to have the amino acid that interacts with the
fifth pocket of the MHC molecule shifted from P9 to P8 (Table
4), whereas Ek ligands show in some cases a shift from P9
to P10 (Table 2). Similar observations have been made for
ligands of class I MHC molecules as well (1). Whether or not
this reflects differences in the pocket structures caused by
polymorphic residues can only be determined by comparing
the crystal structure of both molecules. The influences of the
predicted pockets of Ek and Ed molecules on the selection of
the amino acids at the anchor positions 1, 4, 6 and 9 are
again summarized in Table 5.
Since natural ligands of Es and Eb molecules have been
identified (3,5), we also attempted pocket and motif predic-
tions (lower part of Table 5) and alignment of peptides for
these class II molecules (Table 6). The first predicted pocket
of the E? molecule differs from DR1, E* and Ed molecules at
position P86. Leu at this position should decrease the pocket
volume compared with Gly in DR1 and Ser in Ed molecules,
therefore allowing, analogous to the Ek motif, mainly aliphatic
residues in P1. This is observed in four out of the five peptide
isolated from Es molecules. Eb molecules are identical to Ed
molecules with regard to the amino acids participating in
the first predicted pocket. Aromatic amino acids should be
favored at P1, as we observed for Ed molecules. Indeed, all
three natural Eb ligands carrying Tyr at P1. The pocket for P4
in Es molecules differs from DR1 at p78 (Tyr -> Val) and p"l3
(Phe -» Ser). This should still allow the binding of aliphatic
and polar residues, and should disfavor the presence of
positively charged residues, very similar to the amino acids
observed at P4 for DR1 molecules (14). All six E8 eluted
peptides fulfil this requirement. The second pocket of Eb
molecules is identical to that of Ek molecules, where P4 of
the peptides is occupied by hydrophobic, polar but also
charged residues. The small number of known Eb eluted
peptides have residues at P4 which belong to these groups
of amino acids. The third pocket, accommodating P6 of the
peptide, differs in both Es and Eb molecules from DR1 at
position p"11, where Leu is replaced by Ser (Es) or Cys (Eb).
This exchange should give the pocket, as in Ek molecules,
more room and a more polar character, allowing polar and
slightly bigger amino acids compared with DR1. The fourth
pocket for P7, which is very degenerate in DR1 molecules, is
probably similar in Es molecules and differs in Eb molecules
only at P71, where Arg is replaced by Lys. This exchange is
not expected to alter the pocket specificity, resulting in a very
degenerate specificity at P7 of Es and Eb binding peptides.
The fifth predicted pocket of E9 and Eb molecules is identical
to Ed and Ek, which differ from DR1 at 09 where Trp is
changed to Glu. Therefore, analogous to Ed and Ek, a basic
residue is expected at this position. The natural Eb and E3
ligands can be easily aligned according to this prediction.
This consideration on predicted Eb and Es motifs should be
useful for designing peptides for binding assays, in order to
verify or modify the prediction. In support of our predicted
similarity of Ek and E8 ligand motifs is the finding of Marrack
et al. (11) who could isolate the same pVmicroglobulin (p^m)
peptide as a natural ligand from Ek and Es molecules.
We show that sequencing of peptide pools and individual
ligands provides detailed information on allele-specific motifs
of Ek and for the first time, Ed ligands, allowing to understand
the different requirements for peptides to bind to these two
H-2E molecules. The motifs can be aligned to pockets in
class II E molecules, predicted according to the crystal
structure of the HLA-DR1 molecule. The polymorphisms
between the Ek and Ed molecules at the 'pocket' residues are
reflected in differences within the peptide motifs. The latter
indicate a very high structural similarity of mouse class II E
molecules with human DR molecules. The anchor at relative
position 9 is conserved between all class II E binding peptides
[as suggested by Leighton et al. (7)], whereas P1, P4, P6
and possibly P7 are different and responsible for the allelic
differences. Since all anchor residues contribute to binding,
a suboptimal amino acid selection at one anchor position
may be compensated by an optimal fit at another anchor
residue. This might explain why some peptides can bind to
more than one but not all H-2E molecules. A good example
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Table 6. Alignment of natural ligands and T cell epitopes to the predicted H-2E8 and Eb motifs
H-2E8 motif
Relative position
Predicted anchor residues
Natural ligands8
Carboxypeptidase A 44-
02)7142-
H-2Ld 160-
P-Actin 286-
Substance P receptor 255-261
HSP60 478-492
T cell epitopesb
MCC 95-103
H-2E13 motif
Predicted anchor residues
Natural ligands0
MuLV env protein 454-469
MuLV env protein 454-475
MuLV env protein 454-467
BSA 141-153
Unknown
T cell epitopesb
SNase 81-100
MCC 95-103
1 2 3 4 5 6 . 7 8 9
I
V
L
L
I
V
L
F
Y
Q
E
A
A
V
M
W
P
I
h
1
y
L
h
L
S.
c
K
K
H
T
W
2
H
r
nR
M
L
G
G
Y
K
P
K
K
L
I
F
K
R
K
K
K
K
H
D
N
I
V
G
G
I
F
H P P H I E
E G E C
M Q K E I ' T A
C T
E G S L I V E K I M O . S S S E
1 2 3 4 5 S 7 8 9
w
p
Y
I
E
y
2
N
A
S P S Y V Y H Q E E R R A
S P S Y V Y H Q E E R R A
S P S Y V Y H Q E E R R A
G K Y L Y E I A . R R
X P Q S Y L I H E X X X
F L
Y K
Y K R E P V S L
P Y
S
F Y
R T D K Y G R G L A Y 1 Y A . D G K M V N
X A Y L K Q A T K
"Sequences adapted from ref. 5.
•T cell epitopes adapted from ref. 22.
cSequences adapted from ref. 3.
for this is the MCC 95-103 peptide. It is reported to bind to
£k,b,s molecules (26). P1, 4, 6 and 9 have the optimal amino
acid selection for binding to Ek and E8 molecules and are
nearly optimal for Eb, which should prefer aromatic instead
of aliphatic residues at P1. Ed molecules, on the other hand,
prefer, in addition to aromatic amino acids at P1, basic
residues at P4 and aliphatic residues at P6. MCC 95-103
does not fulfil any of these requirements and, because of this,
might not bind to Ed molecules.
Our analysis shows that structural and sequence information
together can be used to predict allele-specific motifs. /The
four H-2E motifs we have described or predicted in this paper
can be used to identify ligands within proteins supposed to
be recognized during immune responses against infectious
agents or in autoimmune diseases. The identification of such
ligands will be helpful for designing mouse models of active
immune intervention since the design of both subunit vaccines
or MHC antagonist requires a detailed knowledge of anchor
positions and other general rules for peptide presentation by
MHC molecules.
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Abbreviations
a1-antitryp. a1-antitrypsin
fem ^2-microglobulin
Apo-E prec. apolipoprotein E precursor
BSA bovine serum albumin
C inhib. C cytolysis inhibitor
EqMb equine myoglobin
ER60 ER resident protease 60 kDa
Flu PR/8 HA influenza A PR/8/34 hemagglutinin
HEL hen egg fysozyme
HIV-I gag HIV-I gag protein
HLA human lymphocyte antigen
HSC70 heat-shock cognate protein 70
LLO
Xrep
MCC
MoMb
MuLV env
PCC
ser. alb
SNase
SWMb
TFA
listeriotysin 0
X repressor
moth cytochrome c
mouse myoglobin
murine leukemia virus envelope protein
pigeon cytochrome c
serum albumin
staphylococci nuclease
sperm whale myoglobin
trifluoroacetic acid
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